{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:11:43Z","timestamp":1761487903340},"reference-count":19,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.07.042","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T11:23:36Z","timestamp":1187090616000},"page":"7153-7159","source":"Crossref","is-referenced-by-count":21,"title":["A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties"],"prefix":"10.1016","volume":"25","author":[{"given":"Marcela","family":"Henao-Tamayo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula","family":"Junqueira-Kipnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Ordway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gonzales-Juarrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham R.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall J.","family":"Basaraba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian M.","family":"Orme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.vaccine.2007.07.042_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00062752-200201000-00002","article-title":"Toll-like receptors: how they work and what they do","volume":"9","author":"Beutler","year":"2002","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.07.042_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1189\/jlb.0203082","article-title":"How we detect microbes and respond to them: the Toll-like receptors and their transducers","volume":"74","author":"Beutler","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"5428","key":"10.1016\/j.vaccine.2007.07.042_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1126\/science.285.5428.732","article-title":"Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors","volume":"285","author":"Brightbill","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.042_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2567.2000.00093.x","article-title":"Toll-like receptors: molecular mechanisms of the mammalian immune response","volume":"101","author":"Brightbill","year":"2000","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.042_bib5","doi-asserted-by":"crossref","first-page":"L887","DOI":"10.1152\/ajplung.00323.2003","article-title":"Toll-like receptors: function and roles in lung disease","volume":"286","author":"Basu","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.042_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/mi.3.8.466","article-title":"TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression","volume":"3","author":"Vogel","year":"2003","journal-title":"Mol Interv"},{"issue":"7","key":"10.1016\/j.vaccine.2007.07.042_bib7","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.4049\/jimmunol.176.7.4323","article-title":"Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling","volume":"176","author":"Pennini","year":"2006","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.07.042_bib8","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1128\/IAI.72.11.6603-6614.2004","article-title":"Prolonged Toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages","volume":"72","author":"Pai","year":"2004","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2007.07.042_bib9","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1128\/IAI.71.8.4487-4497.2003","article-title":"The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2","volume":"71","author":"Gehring","year":"2003","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.042_bib10","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/cimm.2000.1633","article-title":"Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages","volume":"201","author":"Noss","year":"2000","journal-title":"Cell Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.042_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4049\/jimmunol.171.1.175","article-title":"Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion","volume":"171","author":"Pai","year":"2003","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.07.042_bib12","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1128\/IAI.73.10.6831-6837.2005","article-title":"Effect of deletion or overexpression of the 19-kilodalton lipoprotein Rv3763 on the innate response to Mycobacterium tuberculosis","volume":"73","author":"Stewart","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.042_bib13","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.4049\/jimmunol.175.6.3873","article-title":"Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family","volume":"175","author":"Ordway","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.07.042_bib14","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.vaccine.2005.07.078","article-title":"Preclinical testing of new vaccines for tuberculosis: a comprehensive review","volume":"24","author":"Orme","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.07.042_bib15","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.4049\/jimmunol.167.3.1542","article-title":"Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation","volume":"167","author":"Neufert","year":"2001","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.042_bib16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/423850","article-title":"Induction of apoptosis and release of interleukin-1 beta by cell wall-associated 19-kDa lipoprotein during the course of mycobacterial infection","volume":"190","author":"Ciaramella","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.042_bib17","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/IAI.65.5.1856-1862.1997","article-title":"Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae","volume":"65","author":"Abou-Zeid","year":"1997","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2007.07.042_bib18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-3083.2005.01569.x","article-title":"Increased expression of Mycobacterium tuberculosis 19kDa lipoprotein obliterates the protective efficacy of BCG by polarizing host immune responses to the Th2 subtype","volume":"61","author":"Rao","year":"2005","journal-title":"Scand J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.07.042_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.2000.0252","article-title":"Deletion of the 19kDa antigen does not alter the protective efficacy of BCG","volume":"80","author":"Yeremeev","year":"2000","journal-title":"Tuber Lung Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0700833X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0700833X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T21:11:15Z","timestamp":1587849075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0700833X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":19,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X0700833X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.07.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}